TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26984138

Group type: EXPERIMENTAL
Intervention: Motivational interviewing counseling session
Number of subjects: 53
Study: 24368315

Group type: EXPERIMENTAL
Intervention: Wheat bran extract (WBE) at 5.0 g/day for 3 weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (0 g/day WBE)
Number of subjects: 29
Study: 22390710

Group type: EXPERIMENTAL
Intervention: Social-evaluative threat condition (SET; n = 86)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Nonexplicit social-evaluative threat condition (ne-SET; n = 58)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Social-evaluative threat condition (SET)
Number of subjects: 144
Study: 20498613

Group type: EXPERIMENTAL
Intervention: Music therapy (music-based imagery and music alternate engagement)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (no music)
Number of subjects: 29
Study: 18608977

Group type: EXPERIMENTAL
Intervention: Directed forgetting instruction (to remember)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Directed forgetting instruction (to forget)
Number of subjects: 21
Study: 16052582

Group type: EXPERIMENTAL
Intervention: 10 mg/kg abatacept
Number of subjects: 339

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 339
Study: 12124547

Group type: EXPERIMENTAL
Intervention: Aprotinin (G-2)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (G-1)
Number of subjects: 26
Study: 10626341

Group type: EXPERIMENTAL
Intervention: Sinopril (lisinopril) 10-40 mg daily for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Captopril (capoten) 25-100 mg daily for 8 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both drugs (Sinopril and Captopril)
Number of subjects: 0
Study: 7540856

Group type: EXPERIMENTAL
Intervention: rhGM-CSF at 10 micrograms/kg/d after cyclophosphamide 4 g/m2 i.v.
Number of subjects: 22

Group type: COMPARATOR
Intervention: rhG-CSF at 10 micrograms/kg/d after cyclophosphamide 4 g/m2 i.v.
Number of subjects: 22
Study: 1952777

Group type: EXPERIMENTAL
Intervention: Long acting nitroglycerin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6259740

Group type: EXPERIMENTAL
Intervention: Protocol A: surgery + chemotherapy alone (60 patients)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Protocol B: surgery + radiotherapy + chemotherapy (22 patients)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Protocol C: surgery + chemotherapy (4 cycles) + radiotherapy + chemotherapy (51 patients)
Number of subjects: 137
Study: 31100756

Group type: EXPERIMENTAL
Intervention: Homeopathic medicines prescribed with consideration of individual temperament (temperament(+))
Number of subjects: 50

Group type: COMPARATOR
Intervention: Homeopathic medicines prescribed without consideration of individual temperament (temperament(-))
Number of subjects: 50
Study: 28183546

Group type: EXPERIMENTAL
Intervention: Sevoflurane (VIMA)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Propofol (TIVA)
Number of subjects: 124
Study: 25720624

Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stent (ZES)
Number of subjects: 1606

Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 1606
Study: 24403903

Group type: EXPERIMENTAL
Intervention: Lifestyle changes (healthy diet and physical activity advice)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Red wine (100 ml for women, 200 ml for men daily)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (no lifestyle changes)
Number of subjects: 108
Study: 21146420

Group type: EXPERIMENTAL
Intervention: 30 deep breaths hourly
Number of subjects: 181

Group type: COMPARATOR
Intervention: 10 deep breaths hourly
Number of subjects: 181
Study: 19693752

Group type: EXPERIMENTAL
Intervention: 0.2 % sodium chondroitin sulfate (Gepan instill)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Anticholinergic treatment (Tolterodin)
Number of subjects: 82
Study: 18026577

Group type: EXPERIMENTAL
Intervention: Lactobacilli-fermented milk
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 15662902

Group type: EXPERIMENTAL
Intervention: Guideline recommendations for the diagnosis, treatment, and management of infectious endocarditis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 11142543

Group type: EXPERIMENTAL
Intervention: Traditional child psychotherapy
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control condition (no specific intervention mentioned)
Number of subjects: 53
Study: 9487784

Group type: EXPERIMENTAL
Intervention: Computer-administered version of the Freiburg Personality Inventory (FPI-R)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard paper-pencil questionnaire
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Homogeneous item blocking
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard item arrangement
Number of subjects: 600
Study: 8267694

Group type: EXPERIMENTAL
Intervention: Hyperimmune globulin (HIg) prophylaxis administered from week 1 until week 7 after transplantation
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no HIg prophylaxis)
Number of subjects: 28
Study: 3765736

Group type: EXPERIMENTAL
Intervention: Running group
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Swimming group
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ergometer group
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study: 30129691

Group type: EXPERIMENTAL
Intervention: Passive smartphone data (physical mobility)
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Personalized models combining features
Number of subjects: 271
Study: 30027283

Group type: EXPERIMENTAL
Intervention: Hand-holding
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Stress ball
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control (treatment as usual)
Number of subjects: 135
Study: 27585728

Group type: EXPERIMENTAL
Intervention: Audio-recorded hypnosis with background music
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Music without hypnosis
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study: 24582914

Group type: EXPERIMENTAL
Intervention: Cetuximab (CAPOX-C)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Capecitabine plus oxaliplatin (CAPOX)
Number of subjects: 149
Study: 23089983

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 183
Study: 20103209

Group type: EXPERIMENTAL
Intervention: MitraClip procedure
Number of subjects: 107
Study: 18834364

Group type: EXPERIMENTAL
Intervention: Piroxicam-beta-cyclodextrin sachets (20 mg daily for 28 days)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Piroxicam tablets (20 mg daily for 28 days)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups (sachet and tablets)
Number of subjects: 42
Study: 15947773

Group type: EXPERIMENTAL
Intervention: Doppler transthoracic echocardiography
Number of subjects: 84
Study: 11821652

Group type: EXPERIMENTAL
Intervention: Brief physician advice intervention consisting of two physician visits and two nurse follow-up phone calls.
Number of subjects: 774

Group type: COMPARATOR
Intervention: Control group (n = 382).
Number of subjects: 774

Group type: EXPERIMENTAL
Intervention: Brief physician advice intervention.
Number of subjects: 774
Study: 12412497

Group type: EXPERIMENTAL
Intervention: Behavior with explicit evidence of intent
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: Behavior with greater degree of persistence
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: Gender (female vs male)
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: General community perception
Number of subjects: 1080
Study: 9701410

Group type: EXPERIMENTAL
Intervention: Formoterol 24 microg b.i.d. (by Turbuhaler)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 8029513

Group type: EXPERIMENTAL
Intervention: topical zinc ointment
Number of subjects: 58

Group type: COMPARATOR
Intervention: placebo ointment
Number of subjects: 58
Study: 2532461

Group type: EXPERIMENTAL
Intervention: Cilazapril 2.5 to 5 mg once daily
Number of subjects: 450
Study: 30965072

Group type: EXPERIMENTAL
Intervention: Standardized music therapy (MT) for 15 minutes prior to EEG session (Group 2)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Standardized music therapy (MT) for 15 minutes prior to EEG session plus rubber cap for home practice (Group 3)
Number of subjects: 64

Group type: COMPARATOR
Intervention: No preparation (Group 1)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Standardized music therapy (MT) procedural support during EEG session for all groups
Number of subjects: 64
Study: 28332851

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) treatment
Number of subjects: 126

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 126
Study: 25066733

Group type: EXPERIMENTAL
Intervention: IV n-3PUFA emulsion (0.6 g/kg body weight)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oral n-3PUFA (0.6 g/kg over 3 consecutive days)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Platelet function tests
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: EPA and DHA membrane contents of RBC and platelets
Number of subjects: 8
Study: 22618304

Group type: EXPERIMENTAL
Intervention: High-Intensity Resistance Training (HIT)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Low-Intensity Blood Flow-Restricted Resistance Training (LI-BFR)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control Group (not explicitly mentioned)
Number of subjects: 19
Study: 21399726

Group type: EXPERIMENTAL
Intervention: Valerian officinalis 450 mg orally 1 hour before bedtime for 8 weeks
Number of subjects: 227

Group type: COMPARATOR
Intervention: Placebo orally 1 hour before bedtime for 8 weeks
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Valerian officinalis 450 mg
Number of subjects: 227

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 227

Group type: COMPARATOR
Intervention: Valerian and Placebo
Number of subjects: 227
Study: 18562424

Group type: EXPERIMENTAL
Intervention: Venlafaxine (average dose 103.5 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tricyclic Antidepressants (TCAs) (average dose 106.1 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tricyclic Antidepressants (TCAs)
Number of subjects: 0
Study: 17039666

Group type: EXPERIMENTAL
Intervention: High dose of apple polyphenols
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Low dose of apple polyphenols
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no apple polyphenols)
Number of subjects: 33
Study: 14701886

Group type: EXPERIMENTAL
Intervention: Integrated management approach (early clinical review, education sessions, personal diary for medications and weight, regular clinical follow-up alternating between GP and hospital clinic)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Integrated management approach
Number of subjects: 197
Study: 10688389

Group type: EXPERIMENTAL
Intervention: nabumetone 2000 mg/d
Number of subjects: 346

Group type: COMPARATOR
Intervention: naproxen 1000 mg/d
Number of subjects: 346
Study: 9357406

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium (2 g bolus, followed by 8 g over 24 h)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 8230367

Group type: EXPERIMENTAL
Intervention: Walkman music during epidural anesthesia
Number of subjects: 120

Group type: COMPARATOR
Intervention: Non-music group
Number of subjects: 120
Study: 31876030

Group type: EXPERIMENTAL
Intervention: Multicomponent support groups for people living with rare dementia
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Mixed-methods design including longitudinal cohort study and feasibility RCT
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Qualitative methods including thematic analysis (TA)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Innovative analytical methods involving the arts as a research method
Number of subjects: 1000
Study: 30932161

Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 44

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 44
Study: 28283760

Group type: EXPERIMENTAL
Intervention: Shiatsu plus amitriptyline
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Shiatsu alone
Number of subjects: 37

Group type: COMPARATOR
Intervention: Amitriptyline alone
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Shiatsu (alone or in combination)
Number of subjects: 37
Study: 26439070

Group type: EXPERIMENTAL
Intervention: SF with touch
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: SF with arms' restraint
Number of subjects: 122

Group type: COMPARATOR
Intervention: Standard SF
Number of subjects: 122
Study: 24013651

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab
Number of subjects: 34
Study: 21793278

Group type: EXPERIMENTAL
Intervention: Exteriorized repair
Number of subjects: 338

Group type: COMPARATOR
Intervention: In situ repair
Number of subjects: 338
Study: 19259112

Group type: EXPERIMENTAL
Intervention: Multimicronutrient (MMN) supplementation for 1 year
Number of subjects: 293

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 293
Study: 17077240

Group type: EXPERIMENTAL
Intervention: CA 125 and transvaginal ultrasonography screening
Number of subjects: 28460
Study: 14695733

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg intravenous M6G
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11240595

Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9863106

Group type: EXPERIMENTAL
Intervention: Jinshui Liujun decoction (JSL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline control group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Positive drug Juhong Tanke Ye control group
Number of subjects: 0
Study: 7930724

Group type: EXPERIMENTAL
Intervention: Guillain-Barré syndrome patients
Number of subjects: 42

Group type: COMPARATOR
Intervention: Healthy blood donors
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Patients with positive Campylobacter serology but no neurologic disease
Number of subjects: 42
Study: 3075106

Group type: EXPERIMENTAL
Intervention: Famotidine 20 mg b.i.d.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Famotidine 40 mg b.i.d.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Famotidine 40 mg nocte.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Famotidine single 20 mg bedtime dose.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ranitidine (dosage not specified).
Number of subjects: 0
Study: 29722482

Group type: EXPERIMENTAL
Intervention: ART-Def
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: ART-40W
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: ART-96W
Number of subjects: 130

Group type: COMPARATOR
Intervention: HEU
Number of subjects: 130

Group type: COMPARATOR
Intervention: HU
Number of subjects: 130
Study: 26396163

Group type: EXPERIMENTAL
Intervention: Creative art therapy plus conventional physical therapy
Number of subjects: 118

Group type: COMPARATOR
Intervention: Conventional physical therapy only
Number of subjects: 118
Study: 25704621

Group type: COMPARATOR
Intervention: Protocol C (five-session protocol of TMJ lavage plus viscosupplementation)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Protocol A (high-molecular weight hyaluronic acid)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Protocol B (medium-molecular weight hyaluronic acid)
Number of subjects: 30
Study: 23906869

Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (2.0g in 75mL of normal saline)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 20948886

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 17625502

Group type: EXPERIMENTAL
Intervention: Donepezil 5 mg q.d. for 6 weeks then 10 mg q.d. for 6 weeks
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 250
Study: 16645968

Group type: EXPERIMENTAL
Intervention: zoledronic acid (5 mg)
Number of subjects: 39
Study: 14638485

Group type: EXPERIMENTAL
Intervention: Oral administration of artemether
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Intramuscular administration of artemether
Number of subjects: 15
Study: 15558877

Group type: EXPERIMENTAL
Intervention: Zopiclone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zolpidem
Number of subjects: 0

Group type: COMPARATOR
Intervention: Zopiclone and Zolpidem
Number of subjects: 0
Study: 8864789

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography (TEE)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Computed tomography (CT)
Number of subjects: 44
Study: 1602030

Group type: EXPERIMENTAL
Intervention: Relaxation training as an adjunct to radiation therapy (34 patients)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Education and counseling along with radiation therapy (29 patients)
Number of subjects: 82
Study: 6146762

Group type: EXPERIMENTAL
Intervention: Ultrasound examination at the 19th and 32nd weeks of pregnancy
Number of subjects: 510
Study: 31449472

Group type: EXPERIMENTAL
Intervention: HHV‐6B+ BALF
Number of subjects: 553

Group type: EXPERIMENTAL
Intervention: Antivirals within 3 days pre‐BAL
Number of subjects: 553

Group type: COMPARATOR
Intervention: HHV‐6B‐ BALF
Number of subjects: 553
Study: 28207841

Group type: EXPERIMENTAL
Intervention: 6-PACK falls prevention program implementation
Number of subjects: 420
Study: 26613389

Group type: EXPERIMENTAL
Intervention: L-methylfolate calcium (15 mg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24304196

Group type: EXPERIMENTAL
Intervention: Whole-body cryotherapy (WBC) before physical exercises
Number of subjects: 96

Group type: COMPARATOR
Intervention: Physical exercises only (Control)
Number of subjects: 96
Study: 22672361

Group type: EXPERIMENTAL
Intervention: Full coverage acrylic stabilisation occlusal splint (Group I, n=21)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Anterior device nociceptive trigeminal inhibitory (NTI) system (Group II, n=16)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Counselling for behavioural changes and self-care (Group III, n=14, Control group)
Number of subjects: 51
Study: 19220676

Group type: EXPERIMENTAL
Intervention: i.v. imipenem-cilastatin (3 x 500 mg/day) for 7-14 days
Number of subjects: 56

Group type: COMPARATOR
Intervention: No antibiotic prophylaxis
Number of subjects: 56
Study: 17471802

Group type: EXPERIMENTAL
Intervention: Programmed instruction with progressively added formal prompts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Programmed instruction with one attempt
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prose tutorials
Number of subjects: 0
Study: 15515408

Group type: EXPERIMENTAL
Intervention: 5-HT3 receptor antagonist tropisetron
Number of subjects: 0
Study: 10931125

Group type: EXPERIMENTAL
Intervention: Flow cytometry
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Histamine release
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Leukotriene C4 release
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Skin tests
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Specific IgE
Number of subjects: 55

Group type: COMPARATOR
Intervention: Flow cytometry (controls)
Number of subjects: 55
Study: 9027672

Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerine patches delivering 0.2 or 0.1 mg/h, applied during the first 3 days of the menstrual cycle for up to three consecutive cycles
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerine patches
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo (not explicitly detailed in the abstract)
Number of subjects: 65
Study: 8319191

Group type: EXPERIMENTAL
Intervention: Intermittent intravenous ondansetron with lorazepam and dexamethasone
Number of subjects: 80

Group type: COMPARATOR
Intervention: Continuous-infusion metoclopramide with lorazepam, dexamethasone, and diphenhydramine
Number of subjects: 80
Study: 31414842

Group type: EXPERIMENTAL
Intervention: Internalized stigma
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Low sense of belonging
Number of subjects: 242
Study: 29683030

Group type: EXPERIMENTAL
Intervention: tDCS (anode over the ipsilesional M1 and cathode on the contralesional forehead) during 5 days of training
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sham tDCS (control group)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: tDCS (real tDCS group)
Number of subjects: 56
Study: 26824379

Group type: EXPERIMENTAL
Intervention: Prophylactic nimodipine treatment
Number of subjects: 112

Group type: COMPARATOR
Intervention: No prophylactic nimodipine treatment
Number of subjects: 112
Study: 25020273

Group type: COMPARATOR
Intervention: UMEC/VI 500/100 μg
Number of subjects: 103

Group type: COMPARATOR
Intervention: UMEC/VI 125/25 μg
Number of subjects: 103

Group type: COMPARATOR
Intervention: UMEC 500 μg
Number of subjects: 103

Group type: COMPARATOR
Intervention: Moxifloxacin
Number of subjects: 103

Group type: COMPARATOR
Intervention: UMEC 500/100 μg
Number of subjects: 103
Study: 22133208

Group type: EXPERIMENTAL
Intervention: BUD/FM 160/4.5 μg × 2 inhalations bid
Number of subjects: 311

Group type: COMPARATOR
Intervention: BUD 180 μg × 2 inhalations bid
Number of subjects: 311
Study: 19851815

Group type: EXPERIMENTAL
Intervention: Percutaneous repetitive sclerotherapy using polidocanol (Group 1)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Intralesional excision (extended curettage with a high-speed burr) and bone grafting (Group 2)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Comparison of both groups
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Both treatment methods
Number of subjects: 94
Study: 18539692

Group type: EXPERIMENTAL
Intervention: High-intensity intervention (group A)
Number of subjects: 18280

Group type: EXPERIMENTAL
Intervention: Low-intensity intervention (group B)
Number of subjects: 18280

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 18280

Group type: EXPERIMENTAL
Intervention: Intervention effect among women
Number of subjects: 18280